443 related articles for article (PubMed ID: 25228541)
1. NK1 receptor antagonists as a new treatment for corneal neovascularization.
Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment.
Bignami F; Lorusso A; Rama P; Ferrari G
Acta Ophthalmol; 2017 Nov; 95(7):e641-e648. PubMed ID: 28205389
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring.
Ferrari G; Bignami F; Giacomini C; Franchini S; Rama P
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1680-8. PubMed ID: 23404121
[TBL] [Abstract][Full Text] [Related]
4. Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: an overview of two common animal models of corneal neovascularization.
Giacomini C; Ferrari G; Bignami F; Rama P
Exp Eye Res; 2014 Apr; 121():1-4. PubMed ID: 24560796
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
Kim JW; Jeong H; Yang MS; Lim CW; Kim B
Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
[TBL] [Abstract][Full Text] [Related]
6. Involvement of NADPH oxidases in alkali burn-induced corneal injury.
Gu XJ; Liu X; Chen YY; Zhao Y; Xu M; Han XJ; Liu QP; Yi JL; Li JM
Int J Mol Med; 2016 Jul; 38(1):75-82. PubMed ID: 27221536
[TBL] [Abstract][Full Text] [Related]
7. Topical treatment of corneal alkali burns with Gly-thymosin β
Zhang W; Nie L; Du L; Chen W; Wu Z; Jin Y
Burns; 2017 Dec; 43(8):1742-1747. PubMed ID: 28602595
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RAP1 enhances corneal recovery following alkali injury.
Poon MW; Yan L; Jiang D; Qin P; Tse HF; Wong IY; Wong DS; Tergaonkar V; Lian Q
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):711-21. PubMed ID: 25574050
[TBL] [Abstract][Full Text] [Related]
9. The effect of TC14012 on alkali burn-induced corneal neovascularization in mice.
Shen M; Yuan F; Jin J; Yuan Y
Ophthalmic Res; 2014; 52(1):17-24. PubMed ID: 24853648
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone and MicroRNA-204 Inhibit Corneal Neovascularization.
Zhang X; Wang G; Wang Q; Jiang R
Mil Med; 2024 Jan; 189(1-2):374-378. PubMed ID: 36043264
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn.
Wu Y; Xue C; Lu Y; Huang Z
Indian J Ophthalmol; 2017 Nov; 65(11):1127-1132. PubMed ID: 29133637
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn.
Doganay S; Firat PG; Cankaya C; Kirimlioglu H
Burns; 2013 Mar; 39(2):326-30. PubMed ID: 22922008
[TBL] [Abstract][Full Text] [Related]
13. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
[TBL] [Abstract][Full Text] [Related]
14. Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye.
Zhou C; Robert MC; Kapoulea V; Lei F; Stagner AM; Jakobiec FA; Dohlman CH; Paschalis EI
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):96-105. PubMed ID: 28114570
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical aflibercept versus topical bevacizumab for the prevention of corneal neovascularization in a rat model.
Sella R; Gal-Or O; Livny E; Dachbash M; Nisgav Y; Weinberger D; Livnat T; Bahar I
Exp Eye Res; 2016 May; 146():224-232. PubMed ID: 27020759
[TBL] [Abstract][Full Text] [Related]
16. Transient downregulation of microRNA-206 protects alkali burn injury in mouse cornea by regulating connexin 43.
Li X; Zhou H; Tang W; Guo Q; Zhang Y
Int J Clin Exp Pathol; 2015; 8(3):2719-27. PubMed ID: 26045777
[TBL] [Abstract][Full Text] [Related]
17. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model.
Yu J; Shen Y; Luo J; Jin J; Li P; Feng P; Guan H
Int Immunopharmacol; 2023 Mar; 116():109680. PubMed ID: 36739832
[TBL] [Abstract][Full Text] [Related]
18. Effects of nicotine on corneal wound healing following acute alkali burn.
Kim JW; Lim CW; Kim B
PLoS One; 2017; 12(6):e0179982. PubMed ID: 28644870
[TBL] [Abstract][Full Text] [Related]
19. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
Yoeruek E; Ziemssen F; Henke-Fahle S; Tatar O; Tura A; Grisanti S; Bartz-Schmidt KU; Szurman P;
Acta Ophthalmol; 2008 May; 86(3):322-8. PubMed ID: 17995975
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
